About
Hyprevention is a medtech company founded in 2010, based in Pessac, France, and incorporated in Delaware for U.S. operations. The company specializes in developing, manufacturing, and commercializing orthopedic medical devices that address bone fragility, particularly due to conditions like osteoporosis and cancer. Led by CEO Cécile Vienney, who has extensive experience in orthopedic implantable devices, Hyprevention focuses on meeting significant public health needs. One of its key innovations is STRUTPLASTY®, a proprietary technology that reinforces weakened bones. This solution combines implantable devices made from PEEK, a material that mimics the mechanical properties of natural bone, with PMMA bone cement to treat fractures and prevent new ones. Hyprevention manages the entire product lifecycle, ensuring quality and regulatory compliance while targeting healthcare providers in the U.S., Latin America, and the Middle East who specialize in orthopedic surgery.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2010
-
Total Funding $21374886
Location
Avenue du Haut Leveque, Pessac, Nouvelle-Aquitaine, France, 33604